Skip to main content
Livermore
Livermore
ZHEN

Winton Group Ltd

SEC CIK
0001612063
Latest filing
Aug 7, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Winton Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
1,600
Value
$269.7K
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of NBIX by Winton Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,600$269.7K<0.1%+1,600NewHolders
Q4 20250$00.0%−5,360−100.0%Sold outHolders
Q3 20255,360$752.4K<0.1%+1,957+57.5%AddedHolders
Q2 20253,403$427.7K<0.1%−4,254−55.6%ReducedHolders
Q1 20257,657$846.9K0.1%+136+1.8%AddedHolders
Q4 20247,521$1.03M0.1%+7,521NewHolders
Q3 20240$00.0%−10,689−100.0%Sold outHolders
Q2 202410,689$1.47M0.1%+10,689NewHolders
Q1 20240$00.0%−4,155−100.0%Sold outHolders
Q4 20234,155$547.5K<0.1%−117−2.7%ReducedHolders
Q3 20234,272$480.6K<0.1%+1,738+68.6%AddedHolders
Q2 20232,534$239.0K<0.1%−39,708−94.0%ReducedHolders
Q1 202342,242$4.28M0.3%+12,542+42.2%AddedHolders
Q4 202229,700$3.55M0.2%−16,429−35.6%ReducedHolders
Q3 202246,129$4.90M0.3%+2,849+6.6%AddedHolders
Q2 202243,280$4.22M0.2%+6,773+18.6%AddedHolders
Q1 202236,507$3.42M0.2%−3,954−9.8%ReducedHolders
Q4 202140,461$3.45M0.2%+19,957+97.3%AddedHolders
Q3 202120,504$1.97M0.1%−1,283−5.9%ReducedHolders
Q2 202121,787$2.12M0.1%−955−4.2%ReducedHolders
Q1 202122,742$2.21M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.